NOS3 and chronic obstructive pulmonary disease: These findings indicate that while ADMA is a strong biomarker for acute exacerbations, NO and eNOS may serve as more reliable indicators for identifying stable COPD, highlighting the differential role of the ADMA/NO/eNOS axis across disease phases.